Status:
COMPLETED
Association Between Subtypes of Anti Citrullinated Peptide Antibodies and Lung Damage in Rheumatoid Arthritis
Lead Sponsor:
University Hospital Center of Martinique
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Rheumatoid arthritis is a genuine systemic disease associated with diffuse interstitial pneumopathy and bronchial disorders. According to the literature review, the prevalence of PID on thoracic CT sc...
Eligibility Criteria
Inclusion
- Patient with rheumatoid arthritis ACR/EULAR 2010
- Patient with a higher age or equal to 18
- Patient receiving social security
- Patient giving his free and informed written consent
Exclusion
- Patient with overlap syndrome with another autoimmune disease
- Patients with known severe cardiopulmonary pathology
- Woman who is pregnant and breast feeding
- Patient with language difficulties or understanding
Key Trial Info
Start Date :
June 2 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT03832374
Start Date
June 2 2016
End Date
March 1 2022
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Martinique
Fort-de-France, Martinique, 97261